New product: Ajovy (fremanezumab) 225mg pre-filled syringe for injection -

New product: Ajovy (fremanezumab) 225mg pre-filled syringe for injection
Information type: Drug prescribing
Source: electronic Medicines compendium
Specialities: Neurological disorders
Summary
Fremanezumab is a monoclonal antibody licensed for prophylaxis of migraine, via subcutaneous injection, in adults who have at least four migraine days per month.
UKMi comment
NICE is expected to appraise the clinical and cost effectiveness of fremanezumab within its marketing authorisation for preventing migraine.
Related links:

Terms and Conditions

For feedback or enquiries relating to this service please email: medicinesresources@gstt.nhs.uk